Kansikuva

A DTAP-IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS' CLINICAL EXPERIENCE

Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with...

Tallennettuna:

Bibliografiset tiedot
Päätekijät:	Stanley A. Plotkin (Tekijä), Johannes Liese (Tekijä), Shabir A. Madhi (Tekijä), Esteban Ortiz (Tekijä)
Aineistotyyppi:	Kirja
Julkaistu:	"Paediatrician" Publishers LLC, 2012-01-01T00:00:00Z.
Aiheet:	article
Linkit:	Connect to this object online.
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
Tekijä: Andrew Dakin, et al.
Julkaistu: (2023)

Immunogenicity and safety of a DTaP-IPV//PRP~T combination vaccine given with hepatitis B vaccine: a randomized open-label trial
Tekijä: Maria Rosario Capeding, et al.
Julkaistu: (2008)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
Tekijä: Andrea Guerra, et al.
Julkaistu: (2024)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
Tekijä: Irina V. Mikheeva, et al.
Julkaistu: (2019)

Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
Tekijä: Pope Kosalaraksa, et al.
Julkaistu: (2018)

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
Tekijä: Florence Boisnard, et al.
Julkaistu: (2023)

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
Tekijä: Andrew W. Lee, et al.
Julkaistu: (2017)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
Tekijä: Marissa B. Wilck, et al.
Julkaistu: (2021)

Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China
Tekijä: Aodi Huang, et al.
Julkaistu: (2024)

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
Tekijä: Yiqing Zhu, et al.
Julkaistu: (2024)

Rejoinder to comments on ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China''
Tekijä: Floriano Amimo
Julkaistu: (2024)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
Tekijä: Anitta Ahonen, et al.
Julkaistu: (2022)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
Tekijä: Soon Min Lee, et al.
Julkaistu: (2019)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
Tekijä: Yoshiyuki Tanaka, et al.
Julkaistu: (2017)

Experience and challenges on influenza and pertussis vaccination in pregnant women
Tekijä: Shabir A. Madhi, et al.
Julkaistu: (2018)

Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia
Tekijä: Khaliif Nouh, et al.
Julkaistu: (2024)

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
Tekijä: Sarah J. Clark, et al.
Julkaistu: (2020)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
Tekijä: The MMR-158 Study Group
Julkaistu: (2019)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
Tekijä: V.K. Tatochenko, et al.
Julkaistu: (2006)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
Tekijä: V.K. Tatochenko, et al.
Julkaistu: (2006)

Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis
Tekijä: Shabir A. Madhi
Julkaistu: (2015)

Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis
Tekijä: Shabir A. Madhi
Julkaistu: (2015)

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants
Tekijä: Diego Mpia Elenge, et al.
Julkaistu: (2024)

Dengue vaccines: the road to failure or to success?
Tekijä: Stanley A. Plotkin
Julkaistu: (2020)

Vaccines for epidemic infections and the role of CEPI
Tekijä: Stanley A. Plotkin
Julkaistu: (2017)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
Tekijä: Julianne Bayliss, et al.
Julkaistu: (2021)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
Tekijä: Zhen-jiang LIU, et al.
Julkaistu: (2022)

EXPERIENCE OF USE OF DTAP HEXAVACCINE AT THE VACCINAL PREVENTION UNIT FOR CHILDREN WITH HEALTH DEVIATIONS OF THE SCIENTIFIC CENTER OF CHILDREN'S HEALTH (FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION)
Tekijä: T. A. Grechukha, et al.
Julkaistu: (2014)

Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines
Tekijä: Sonwabile Dzanibe, et al.
Julkaistu: (2018)

IPV Screening and Readiness to Respond to IPV in Ob-Gyn Settings: A Patient-Physician Study
Tekijä: Katherine M. Jones, et al.
Julkaistu: (2018)

Design and testing of an experimental IPv4-to-IPv6 transition network / Mustaffa Samad
Tekijä: Samad, Mustaffa
Julkaistu: (2006)

Special focus on challenges and opportunities for the development and use of vaccines in Africa
Tekijä: Shabir A. Madhi, et al.
Julkaistu: (2018)

Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
Tekijä: Sabelle Jallow, et al.
Julkaistu: (2017)

Implementasi Interkoneksi IPV6 Dan IPV4 Menggunakan Clearos Enterprise 5.1
Tekijä: Aghi, Risada, et al.
Julkaistu: (2013)

The progress of postapproval clinical studies on Sabin IPV
Tekijä: Li Shi, et al.
Julkaistu: (2022)

Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022
Tekijä: Qinghua Chen, et al.
Julkaistu: (2024)

Performance comparison of multimedia application over IPv4 and IPv6 network / Ummi Suraya Shaharuddin
Tekijä: Shaharuddin, Ummi Suraya
Julkaistu: (2016)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
Tekijä: Camila Cristina Martini Rodrigues, et al.
Julkaistu: (2022)

Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis
Tekijä: Marta C. Nunes, et al.
Julkaistu: (2018)

Proactive surveillance on DTaP vaccination-induced adverse local reac-tions among infants in a county of Jiangsu province
Tekijä: Peng ZHANG, et al.
Julkaistu: (2024)